Cite
APA Citation
Elbitar, S., Khoury, P. E., Ghaleb, Y., Rabès, J., Varret, M., Seidah, N. G., Boileau, C., & Abifadel, M. (n.d.). proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015). Expert opinion on therapeutic patents, 26, 1377–1392. http://access.bl.uk/ark:/81055/vdc_100039134318.0x000012